Literature DB >> 495342

Histamine H1-and H2-receptors in coronary arteries of pigs.

M Hagen, I Paegelow.   

Abstract

Histamine exerts its action in smooth muscle via in two types of receptors. In coronary arteries of pigs both types of receptors are also involved in responses to histamine. Histamine initiates by an interaction with H1-receptors a contraction and with H2-receptors a relaxation. The histamine-induced contraction is reduced by the competitively antagonistic action of mepyramine. Metiamide potentiates dose-dependently the histamine-caused contraction in the absence and presence of mepyramine. The proportion of H2-receptors in relation to H1-receptors is calculated.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 495342     DOI: 10.1007/bf01966697

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  14 in total

1.  Histamine H2-receptors in the human peripheral circulation.

Authors:  P Chipman; W E Glover
Journal:  Br J Pharmacol       Date:  1976-04       Impact factor: 8.739

2.  A comparison of the effects of bradykinin, 5-hydroxytryptamine and histamine on the hepatic arterial and portal venous vascular beds of the dog: histamine H1 and H2-receptor populations.

Authors:  P D Richardson; P G Withrington
Journal:  Br J Pharmacol       Date:  1977-05       Impact factor: 8.739

3.  Classification and biological distribution of histamine receptor sub-types.

Authors:  N Chand; P Eyre
Journal:  Agents Actions       Date:  1975-10

4.  Identification and blockade of vascular H2 receptors.

Authors:  J R Powell; M J Brody
Journal:  Fed Proc       Date:  1976-06

5.  Definition and antagonism of histamine H 2 -receptors.

Authors:  J W Black; W A Duncan; C J Durant; C R Ganellin; E M Parsons
Journal:  Nature       Date:  1972-04-21       Impact factor: 49.962

6.  Receptors mediating some actions of histamine.

Authors:  A S Ash; H O Schild
Journal:  Br J Pharmacol Chemother       Date:  1966-08

7.  Histamine in the pigs: determination, distribution, release and pharmacological actions.

Authors:  W Lorenz; H Barth; J Kusche; H J Reimann; A Schmal; E Metejka
Journal:  Eur J Pharmacol       Date:  1971-04       Impact factor: 4.432

8.  The cardiovascular effects of histamine in laboratory animals.

Authors:  R W Brimblecombe; D A Owen; M E Parsons
Journal:  Agents Actions       Date:  1974-08

9.  Proceedings: Histamine receptors in the cardiovascular system of the cat.

Authors:  D A Owen; M E Parsons
Journal:  Br J Pharmacol       Date:  1974-05       Impact factor: 8.739

10.  The effects of histamine and some histamine-like agonists on blood pressure in the cat.

Authors:  D A Owen
Journal:  Br J Pharmacol       Date:  1975-10       Impact factor: 8.739

View more
  6 in total

Review 1.  [Histamine effects on the heart with special reference to cardiac side effects of H2 receptor antagonists].

Authors:  D Baller; H Huchzermeyer
Journal:  Klin Wochenschr       Date:  1989-08-01

2.  Temporal changes in the calcium-force relation during histamine-induced contractions of strips of the coronary artery of the pig.

Authors:  K Hirano; H Kanaide; S Abe; M Nakamura
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

3.  Different mechanisms of action of histamine in isolated arteries of the dog.

Authors:  M Konishi; N Toda; M Yamamoto
Journal:  Br J Pharmacol       Date:  1981-09       Impact factor: 8.739

4.  Effects of histamine H1-receptor stimulation on coronary hemodynamics in man.

Authors:  C Vigorito; S Poto; M Triggiani; M Rispoli; G Marone
Journal:  Agents Actions       Date:  1985-10

5.  Histamine H3-receptor activation augments voltage-dependent Ca2+ current via GTP hydrolysis in rabbit saphenous artery.

Authors:  M Oike; K Kitamura; H Kuriyama
Journal:  J Physiol       Date:  1992-03       Impact factor: 5.182

6.  UDP-sugars activate P2Y14 receptors to mediate vasoconstriction of the porcine coronary artery.

Authors:  Zainab S B Abbas; M Liaque Latif; Natalia Dovlatova; Sue C Fox; Stan Heptinstall; William R Dunn; Vera Ralevic
Journal:  Vascul Pharmacol       Date:  2017-12-15       Impact factor: 5.773

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.